Latest Cachexia Stories
Experts say severe malnutrition and weight loss play a role in at least one in five cancer deaths and now American institutions are making changes to combat this.
A U.S. physician suggests doctors are not doing enough to pick up on problems associated with excessive weight loss -- a condition called cachexia. Dr.
Doctors are not doing enough to pick up on problems with excessive weight loss, says a Saint Louis University physician who helped draft recent guidelines to diagnose the condition called "cachexia" (kuh-kex-ee-uh).
Tranzyme Pharma, a biopharmaceutical company engaged in the discovery and clinical development of first-in-class small molecule therapeutics, announced that Dr.
GTx, a biopharmaceutical company, has announced positive topline results of a Phase II clinical trial evaluating Ostarine, an investigational selective androgen receptor modulator, in patients with cancer induced muscle loss, also known as cancer cachexia.
GTx, Inc. (NASDAQ: GTXI) today announced topline results of a Phase II clinical trial evaluating Ostarine(TM) (MK-2866), an investigational selective androgen receptor modulator (SARM), in patients with cancer induced muscle loss, also known as cancer cachexia.
Advanced Viral Research Corp. (OTCBB: ADVR), a cancer therapeutics company, announced today that it has received two Notices of Allowance for patents related to alleviating side effects in patients undergoing treatments for cancer. The first Notice of Allowance is from the U.S.
A new study provides important insight into the mechanisms of a muscle wasting disorder that interferes with treatment for cancer and has a negative impact on patient survival. The research, published in the November issue of Cancer Cell, describes an unexpected link between muscular dystrophy and muscle wasting associated with cancer, and suggests a potential strategy for development of therapies to combat cancer-associated muscle wasting.
Researchers at Oregon Health & Science University's Doernbecher Children's Hospital have uncovered a unique therapeutic strategy to combat cachexia -- severe malnutrition and physical wasting away -- in children and adults with chronic kidney disease (CKD). The study is published in the June issue of the Journal of Clinical Investigation.
PhytoMedical Technologies, Inc.
- A political dynamiter.